Stocks

The table gives an overview of all stocks, alphabetically sorted.
 A-Mark Precious Metals, Inc. AMRK Oct 20, 2017 16.15 -0.62   
 A. Schulman SHLM Oct 20, 2017 36.25 +0.69   
 Aaon Inc AAON Oct 20, 2017 34.60 +1.17   
 Abaxis Inc ABAX Oct 20, 2017 47.04 +0.51   
 Abeona Therapeutics Inc. ABEO Oct 20, 2017 19.00 +7.04   
 Abeona Therapeutics Inc. ABEOW Oct 20, 2017 14.21 +12.15   
 Ability Inc. ABIL Oct 20, 2017 0.70 -2.64   
 Abiomed ABMD Oct 20, 2017 174.62 +1.40   
 Abraxas Petroleum Corp AXAS Oct 20, 2017 1.96 -1.51   
 AC Immune SA ACIU Oct 20, 2017 11.87 +1.02   
 Acacia Communications, Inc. ACIA Oct 20, 2017 44.93 +1.01   
 Acacia Research Corp ACTG Oct 20, 2017 4.20 +2.44   
 Acadia Healthcare Company Inc ACHC Oct 20, 2017 44.45 +0.66   
 Acadia Pharmaceuticals Inc ACAD Oct 20, 2017 36.32 +1.37   
 Acasti Pharma Inc ACST Oct 20, 2017 1.30 0.00   
 Accelerate Diagnostics Inc AXDX Oct 20, 2017 19.85 -0.50   
 Acceleron Pharma Inc XLRN Oct 20, 2017 36.57 -1.98   
 Access National Corp ANCX Oct 20, 2017 28.50 +0.04   
 Accuray Incorporated ARAY Oct 20, 2017 4.30 0.00   
 Acelrx Pharmaceuticals ACRX Oct 20, 2017 2.00 +14.29   
 Aceto Corp ACET Oct 20, 2017 11.27 +0.09   
 Achaogen, Inc. AKAO Oct 20, 2017 13.88 -3.14   
 Achillion Pharmaceuticals ACHN Oct 20, 2017 4.15 -0.24   
 Aci Worldwide ACIW Oct 20, 2017 24.20 +1.13   
 Aclaris Therapeutics, Inc. ACRS Oct 20, 2017 26.09 -2.03   
 Acnb Corp ACNB Oct 20, 2017 28.30 +0.89   
 Acorda Therapeutics ACOR Oct 20, 2017 27.20 +1.87   
 Acorn Energy ACFN Oct 20, 2017 0.21 -0.39   
 Active Alts Contrarian ETF SQZZ Oct 20, 2017 25.01 -0.29   
 Activision Blizzard Inc ATVI Oct 20, 2017 62.63 +1.03   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here www.investtech.com/disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK